The purpose of this study is to look at the effectiveness of giving cemiplimab and XL092 before and after surgery for Anaplastic Thyroid Cancer.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Sid Sheth
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Thyroid and Other Gland/Endocrine)
24-3051
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
